Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 98,188 |
|
|||||
| News | - | ||||||
| Day High | 25.09 | Low High |
|||||
| Day Low | 21.70 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Gyre Therapeutics Inc | GYRE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.29 | 1.23% | 23.81 | 18:42:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 22.52 | 21.70 | 25.09 | 23.40 | 23.52 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,797 | 98,188 | $ 23.37 | $ 2,294,184 | - | 5.88 - 27.3889 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:59 | 7 | $ 22.51 | USD |
Gyre Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 60.28M | - | - | - | -731.45 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Gyre Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GYRE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.21 | 27.3889 | 16.95 | 22.92 | 249,282 | 6.60 | 38.35% |
| 1 Month | 6.40 | 27.3889 | 6.32 | 17.98 | 128,279 | 17.41 | 272.03% |
| 3 Months | 7.00 | 27.3889 | 5.88 | 17.45 | 116,168 | 16.81 | 240.14% |
| 6 Months | 7.00 | 27.3889 | 5.88 | 17.45 | 116,168 | 16.81 | 240.14% |
| 1 Year | 7.00 | 27.3889 | 5.88 | 17.45 | 116,168 | 16.81 | 240.14% |
| 3 Years | 7.00 | 27.3889 | 5.88 | 17.45 | 116,168 | 16.81 | 240.14% |
| 5 Years | 7.00 | 27.3889 | 5.88 | 17.45 | 116,168 | 16.81 | 240.14% |
Gyre Therapeutics Description
| Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants. |
